Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Dutasteride significantly improved hair health and reduced shedding for a woman with PCOS and hyperandrogenism, without causing depression or anxiety, unlike finasteride. Dutasteride also helped with PMDD symptoms and had no side effects, though it changed hair texture.

A 22-year-old male experienced increased testosterone and estradiol levels after 8 months on finasteride, leading to softer erections and reduced arousal. Suggestions included reducing finasteride dosage, using supplements like L-arginine, L-citrulline, zinc, and possibly tadalafil to improve symptoms.

Finasteride use led to a slight increase in estradiol and some erectile dysfunction, but libido remained good. Suggestions included monitoring weight, exercising, and considering supplements like Yohimbe and Tongkat Ali to manage side effects.

Some individuals taking finasteride for hair loss report increased libido and frequent masturbation, with no immediate hair regrowth but darker hair appearance. A dermatologist explains that finasteride may raise testosterone levels temporarily, which could lead to increased sex drive in some people.

Finasteride and dutasteride can cause muted orgasms and reduced sensation, possibly due to hormonal imbalances like increased estrogen or reduced DHT. Some users report improvement by adjusting dosages or stopping the medication.

A user experienced initial side effects from finasteride, including erectile dysfunction and emotional changes, but later noticed increased muscle mass and assertiveness. Hormonal tests showed elevated estrogen and prolactin levels, which slightly decreased over time; the user plans lifestyle changes to see if they help.

The conversation discusses using Tribulus Terrestris and Zinc to boost libido while on finasteride, with some users reporting success in increasing libido despite no testosterone boost. The original poster also considers reducing finasteride dosage and using Cialis for libido and bodybuilding purposes.

Finasteride affects libido differently in individuals due to hormonal changes, increasing testosterone and potentially estrogen, which can either boost or reduce sexual desire. Other treatments mentioned include dutasteride and topical applications, with some users experiencing increased libido and others experiencing a decrease.

Clascoterone has shown promising results in increasing hair density without systemic side effects, potentially offering benefits similar to finasteride. There is skepticism due to the lack of published photos despite the market interest.

After 3.5 months on 1mg finasteride daily, the user experienced elevated free testosterone levels and hair thinning, with side effects like low libido and watery semen. Concerns were raised about hormone levels, with suggestions to monitor estradiol levels.

Minoxidil use led to significant eyelash and eyebrow growth, making the user appear more feminine. The user hopes for similar results on scalp hair.

Finasteride use resulted in increased hair growth but reduced libido for some, leading users to consider topical versions to lessen side effects. Opinions varied on the trade-off between hair benefits and sexual side effects.

Clascoterone is promising for hair loss, showing 24.5% improvement in satisfaction compared to placebo. Users consider it an alternative to finasteride, with concerns about absorption and side effects.

The user discusses experiencing changes in libido and erections while on finasteride, noting that supplements like tongkat, citrulline, arginine, zinc, and vitamin D help maintain morning erections. Other users share varied experiences with finasteride, with some reporting reduced libido and weaker erections, while others notice no significant changes.

Clascoterone stopped shedding for one user, but no visual regrowth was noted after 3 months. The user experienced side effects with finasteride, dutasteride, and RU58841, but not with oral minoxidil and clascoterone.

Creatine may not significantly boost libido despite potentially raising DHT levels. Finasteride reduces DHT and may affect libido, but individual experiences vary.

A user experienced libido issues after using finasteride for five months, with elevated prolactin and estradiol levels. The discussion includes differing opinions on whether these symptoms are due to hormonal imbalances or post-finasteride syndrome.

A user is participating in a phase 3 trial for Clascoterone, a topical acne medication that may stimulate hair growth, and will share results after 6 months. They will have a section of their hair shaved and marked with a tattoo for the study.

Clascoterone 5% shows promising hair growth results but is criticized for high cost and unclear effectiveness compared to other treatments like finasteride. Glenmark is testing a combination of Clascoterone 7.5% and Minoxidil 5% in India.

Clascoterone 5% solution showed a 539% improvement in hair count compared to placebo, but the actual increase in hair growth is minimal. Users express skepticism about the effectiveness of hair loss treatments.

Finasteride may affect prostate sensation and size, with some users reporting easier urination. Concerns exist about prostate shrinkage even at lower doses.

After nearly four months on finasteride, a user noticed improved hair quality but developed nipple puffiness, suggesting early signs of gynecomastia. They considered switching to other treatments like CB-03-01 or RU58841 and contemplated consulting an endocrinologist about aromatase inhibitors.

Minoxidil, dutasteride, and finasteride treatments have significantly increased eyelash length, with some users experiencing eyelashes over twice the average length. Many users report increased hair growth in unintended areas, such as knuckles and body hair, while still struggling with hair loss on the scalp.

The user is considering increasing their dutasteride dose and trying clascoterone or RU58841 for hair loss stabilization. They have used finasteride, minoxidil, and dutasteride, with some success but recent setbacks.

The user experienced tiny vellus hairs from 0.5mg finasteride and 2.5mg minoxidil over 9 months. Topical minoxidil, alfatradiol, and RU58841 applied twice daily for 1.5 months significantly improved temple hair regrowth.

The user is experiencing breast tissue growth from taking dutasteride and minoxidil, and is considering reducing the dosage or stopping the medication. Suggestions include seeing an endocrinologist, using Raloxifene or Arimidex, and considering topical treatments or surgery if necessary.

A 20-year-old male experienced low libido after taking finasteride for 1.5 years and considered switching to topical finasteride. He noticed libido changes with different dosing schedules and questioned if creatine might be affecting his libido.

A 31-year-old experienced significant hair regrowth after switching to oral Finasteride but reported dull orgasms as a side effect. Users suggested waiting for the body to adjust, reducing the dosage, or switching to topical Finasteride to manage side effects.

Clascoterone 5% solution shows strong potential for hair growth, offering a new treatment for alopecia with minimal side effects. It blocks androgen receptors locally and may be available by late 2026 or early 2027.

Finasteride can reduce semen volume due to prostate shrinkage but doesn't affect fertility. To increase semen volume, consider zinc, lecithin, and reducing finasteride dosage.